Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Phase 1positiveCMND-100Positive

AI Analysis

Summary

Clearmind Medicine announced successful completion of Part A of its Phase I/II clinical trial evaluating CMND-100 for alcohol use disorder treatment. All participants in Part A completed treatment.

Clinical Trial Data

Phase

Phase I/II

Outcome Details

Successful completion of treatment for all participants in Part A of Phase I/II trial

Importance:5/10

Sentiment:

0.70

neuroplastogenaddictionweight managementclinical trialPhase I/II

Related Companies

$CMND

Read the original article

Published by GlobeNewswire Clinical Studies on July 28, 2026 11:47 AM

Read Original